Anti-viral immune enhancer properties of some micro-nutrients and functional Herbs with the potential to augment the treatment of COVID-19 patients

[1]   L. Wang, Y. Wang, D. Ye, and Q. Liu, “A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence,” Int. J. Antimicrob. Agents, p. 105948, Mar. 2020.

[2]   W. B. Grant, H. Lahore, S. L. McDonnell, C. A. Baggerly, C. B. French, J. L. Aliano, and H. P. Bhattoa, “Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths,” Nutrients, vol. 12, no. 4, pp. 1–19, 2020.

[3]   N. S. Zhong, B. J. Zheng, Y. M. Li, L. L. M. Poon, Z. H. Xie, K. H. Chan, P. H. Li, S. Y. Tan, Q. Chang, J. P. Xie, X. Q. Liu, J. Xu, D. X. Li, K. Y. Yuen, J. S. M. Peiris, and Y. Guan, “Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003,” Lancet, vol. 362, no. 9393, pp. 1353–1358, Oct. 2003.

[4]   A. Assiri, A. McGeer, T. M. Perl, C. S. Price, A. A. Al Rabeeah, D. A. T. Cummings, Z. N. Alabdullatif, M. Assad, A. Almulhim, H. Makhdoom, H. Madani, R. Alhakeem, J. A. Al-Tawfiq, M. Cotten, S. J. Watson, P. Kellam, A. I. Zumla, and Z. A. Memish, “Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus,” N. Engl. J. Med., vol. 369, no. 5, pp. 407–416, Aug. 2013.

[5]   S. Kouhpayeh, L. Shariati, M. Boshtam, I. Rahimmanesh, M. Mirian, Y. Esmaeili, M. Najaflu, N. Khanahmad, M. Zeinalian, M. Trovato, F. R. Tay, H. Khanahmad, and P. Makvandi, “The molecular basis of covid-19 pathogenesis, conventional and nanomedicine therapy,” Int. J. Mol. Sci., vol. 22, no. 11, 2021.

[6]   R. Gupta, A. Ghosh, A. K. Singh, and A. Misra, “Clinical considerations for patients with diabetes in times of COVID-19 epidemic,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 14, no. 3. Elsevier Ltd, pp. 211–212, May-2020.

[7]   Ahmed Ab. Jabbar, “The Correlation Study between Some Biochemical Parameters of 256 Covid-19 Cases Considering Diabetes,” Indian J. Forensic Med. Toxicol., vol. 15, no. 4 SE-Articles, pp. 277–287, Aug. 2021.

[8]   S. McAuliffe, S. Ray, E. Fallon, J. Bradfield, T. Eden, M. Kohlmeier, S. John, and P. Sumantra Ray, “Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare NNEdPro Global Centre for Nutrition,” BMJ Nutr. Prev. Heal., vol. 0, 2020.

[9]   Y. Galali, “The impact of COVID-19 confinement on the eating habits and lifestyle changes: A cross sectional study,” Food Sci. Nutr., vol. 9, pp. 2105–2113, 2021.

[10] Y. Galali, S. Zebari, K. Younis, Z. Rizgar, N. Sidiq, and B. Taha, “Influence of the COVID-19 Lockdown on the Lifestyles and Eating Behavior of Cihan University Students,” Cihan Univ. Sci. J., vol. 6, no. 2, pp. 141–146, 2022.

[11] E. Stachowska, M. Folwarski, D. Jamioł-Milc, D. Maciejewska, and K. Skonieczna-Żydecka, “Nutritional Support in Coronavirus 2019 Disease,” Medicina (B. Aires)., vol. 56, no. 6, p. 289, Jun. 2020.

[12] S. McAuliffe, S. Ray, E. Fallon, J. Bradfield, T. Eden, and M. Kohlmeier, “Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare,” BMJ Nutr. Prev. Heal., vol. 3, no. 1, p. 93, 2020.

[13] M. Omar, S. Elfagi, and F. Nouh, “Covid-19 and Nutrition: Review of Available Evidence,” Sch. J. Appl. Med. Sci., vol. 08, no. 04, pp. 1158–1164, Apr. 2020.

[14] K. Khanna, S. K. Kohli, R. Kaur, A. Bhardwaj, V. Bhardwaj, P. Ohri, A. Sharma, A. Ahmad, R. Bhardwaj, and P. Ahmad, “Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle,” Phytomedicine, vol. 85, pp. 1–20, May 2021.

[15] M. M. Rahman, A. Mosaddik, and A. K. Alam, “Traditional foods with their constituent’s antiviral and immune system modulating properties,” Heliyon, vol. 7, no. 1, p. e05957, 2021.

[16] H. B. Holem, K. M. Khalid, A. H. Hasan, S. M. Tahir, S. Ubur, and K. Galalaey, “Estimation of total tannin and total phenolic content in plant (Crataegus azarolus L) by orbital shaker technique,” Int. J. Agric. Environ. Food Sci., vol. 1, no. 5, pp. 1–6, 2021.

[17] M. S. Arshad, U. Khan, A. Sadiq, W. Khalid, M. Hussain, A. Yasmeen, Z. Asghar, and H. Rehana, “Coronavirus disease (COVID-19) and immunity booster green foods: A mini review,” Food Sci. Nutr., vol. 8, no. 8, pp. 3971–3976, 2020.

[18] S. Maggini, A. Pierre, and P. C. Calder, “Immune function and micronutrient requirements change over the life course,” Nutrients, vol. 10, no. 10, 2018.

[19] J. A. Beard, A. Bearden, and R. Striker, “Vitamin D and the anti-viral state,” J. Clin. Virol., vol. 50, no. 3, pp. 194–200, 2011.

[20] L. Zhang and Y. Liu, “Potential interventions for novel coronavirus in China: A systematic review,” J. Med. Virol., vol. 92, no. 5, pp. 479–490, May 2020.

[21] D. A. Jolliffe, L. Greenberg, R. L. Hooper, C. Mathyssen, R. Rafiq, R. T. De Jongh, C. A. Camargo, C. J. Griffiths, W. Janssens, and A. R. Martineau, “Vitamin D to prevent exacerbations of COPD: Systematic review and meta-analysis of individual participant data from randomised controlled trials,” Thorax, vol. 74, no. 4, pp. 337–345, Apr. 2019.

[22] Z. Xie, W. Xia, Z. Zhang, W. Wu, C. Lu, S. Tao, L. Wu, J. Gu, J. Chandler, S. Peter, H. Yuan, T. Wu, and E. Liao, “Prevalence of vitamin d inadequacy among chinese postmenopausal women: A nationwide, multicenter, cross-sectional study,” Front. Endocrinol. (Lausanne)., vol. 10, no. JAN, 2019.

[23] H. J. Yu, M. J. Kwon, H. Y. Woo, and H. Park, “Analysis of 25-Hydroxyvitamin D Status According to Age, Gender, and Seasonal Variation,” J. Clin. Lab. Anal., vol. 30, no. 6, pp. 905–911, Nov. 2016.

[24] C. F. Gunville, P. M. Mourani, and A. A. Ginde, “The role of vitamin D in prevention and treatment of infection,” Inflamm. Allergy - Drug Targets, vol. 12, no. 4, pp. 239–245, 2013.

[25] Abhimanyu and A. K. Coussens, “The role of UV radiation and Vitamin D in the seasonality and outcomes of infectious disease,” Photochem. Photobiol. Sci., vol. 16, no. 3, pp. 314–338, Mar. 2017.

[26] A. F. Gombart, A. Pierre, and S. Maggini, “A review of micronutrients and the immune system–working in harmony to reduce the risk of infection,” Nutrients, vol. 12, no. 1, pp. 1–41, Jan. 2020.

[27] P. O. Lang and R. Aspinall, “Vitamin D Status and the Host Resistance to Infections: What It Is Currently (Not) Understood,” Clin. Ther., vol. 39, no. 5, pp. 930–945, May 2017.

[28] M. Rondanelli, A. Miccono, S. Lamburghini, I. Avanzato, A. Riva, P. Allegrini, M. A. Faliva, G. Peroni, M. Nichetti, and S. Perna, “Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages an,” Evid. Based. Complement. Alternat. Med., vol. 2018, p. 5813095, 2018.

[29] M. Teymoori-Rad, F. Shokri, V. Salimi, and S. M. Marashi, “The interplay between vitamin D and viral infections,” Rev. Med. Virol., vol. 29, no. 2, p. e2032, Mar. 2019.

[30] J. Charan, J. P. Goyal, D. Saxena, and P. Yadav, “Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis,” J. Pharmacol. Pharmacother., vol. 3, no. 4, pp. 300–303, Oct. 2012.

[31] P. T. Liu, S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zügel, R. L. Gallo, D. Eisanberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, and R. L. Modlin, “Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response,” Science (80-. )., vol. 311, no. 5768, pp. 1770–1773, Mar. 2006.

[32] J. Agier, M. Efenberger, and E. Brzezińska-Blaszczyk, “Cathelicidin impact on inflammatory cells,” Cent. Eur. J. Immunol., vol. 40, no. 2, pp. 225–235, 2015.

[33] E. Ramos-Martínez, M. R. López-Vancell, J. C. Fernández de Córdova-Aguirre, J. Rojas-Serrano, A. Chavarría, A. Velasco-Medina, and G. Velázquez-Sámano, “Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression,” Cytokine, vol. 108, pp. 239–246, Aug. 2018.

[34] C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, and B. Cao, “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” Lancet, vol. 395, no. 10223, pp. 497–506, Feb. 2020.

[35] A. Sharifi, H. Vahedi, S. Nedjat, H. Rafiei, and M. J. Hosseinzadeh‐Attar, “Effect of single‐dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo‐controlled trial,” APMIS, vol. 127, no. 10, pp. 681–687, Oct. 2019.

[36] T. Zarubin and J. Han, “Activation and signaling of the p38 MAP kinase pathway,” Cell Res., vol. 15, no. 1, pp. 11–18, 2005.

[37] K. R. Short, K. Kedzierska, and C. E. van de Sandt, “Back to the Future: Lessons Learned From the 1918 Influenza Pandemic,” Front. Cell. Infect. Microbiol., vol. 8, p. 343, 2018.

[38] G. S. Lei, C. Zhang, B. H. Cheng, and C. H. Lee, “Mechanisms of action of vitamin D as supplemental therapy for Pneumocystis pneumonia,” Antimicrob. Agents Chemother., vol. 61, no. 10, 2017.

[39] S. Galmés, F. Serra, and A. Palou, “Vitamin E metabolic effects and genetic variants: A challenge for precision nutrition in obesity and associated disturbances,” Nutrients, vol. 10, no. 12, p. 1919, Dec. 2018.

[40] S. N. Meydani, “Vitamin E Supplementation and In Vivo Immune Response in Healthy Elderly Subjects,” JAMA, vol. 277, no. 17, p. 1380, May 1997.

[41] M. Beck, P. C. Kolbeck, L. H. Rohr, Q. Shi, V. C. Morris, and O. A. Levander, “Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice.,” J. Nutr., vol. 124, no. 3, pp. 345–58, Mar. 1994.

[42] M. Mileva and A. S. Galabov, “Vitamin E and Influenza Virus Infection,” in Vitamin E in Health and Disease, InTech, 2018.

[43] M. de la Fuente, M. D. Ferrández, M. S. Burgos, A. Soler, A. Prieto, and J. Miquel, “Immune function in aged women is improved by ingestion of vitamins C and E.,” Can. J. Physiol. Pharmacol., vol. 76, no. 4, pp. 373–80, Apr. 1998.

[44] M. J. Kesic, S. O. Simmons, R. Bauer, and I. Jaspers, “Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells,” Free Radic. Biol. Med., vol. 51, no. 2, pp. 444–453, Jul. 2011.

[45] Y. Yageta, Y. Ishii, Y. Morishima, H. Masuko, S. Ano, T. Yamadori, K. Itoh, K. Takeuchi, M. Yamamoto, and N. Hizawa, “Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice.,” J. Virol., vol. 85, no. 10, pp. 4679–90, May 2011.

[46] B. J. Nonnecke, J. L. McGill, J. F. Ridpath, R. E. Sacco, J. D. Lippolis, and T. A. Reinhardt, “Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves,” J. Dairy Sci., vol. 97, no. 9, pp. 5566–5579, Sep. 2014.

[47] M. Mileva, R. Bakalova, L. Tancheva, and A. S. Galabov, “Effect of immobilization, cold and cold-restraint stress on liver monooxygenase activity and lipid peroxidation of influenza virus-infected mice,” Arch. Toxicol., vol. 76, no. 2, pp. 96–103, Mar. 2002.

[48] M. Kańtoch, B. Litwińska, M. Szkoda, and J. Siennicka, “Importance of vitamin A deficiency in pathology and immunology of viral infections,” Rocz. Panstw. Zakl. Hig., vol. 53, no. 4, pp. 385–92, 2002.

[49] R. D. Semba, “Vitamin A and immunity to viral, bacterial and protozoan infections.,” Proc. Nutr. Soc., vol. 58, no. 3, pp. 719–27, Aug. 1999.

[50] R. D. Semba, P. G. Miotti, J. D. Chiphangwi, G. Liomba, L.-P. Yang, A. J. Saah, G. A. Dallabetta, and D. R. Hoover, “Infant Mortality and Maternal Vitamin A Deficiency During Human Immunodeficiency Virus Infection,” Clin. Infect. Dis., vol. 21, no. 4, pp. 966–972, Oct. 1995.

[51] M. J. Dibley, T. Sadjimin, C. L. Kjolhede, and L. H. Moulton, “Vitamin A supplementation fails to reduce incidence of acute respiratory illness and diarrhea in preschool-age Indonesian children.,” J. Nutr., vol. 126, no. 2, pp. 434–42, Feb. 1996.

[52] C. Cameron, F. Dallaire, C. Vézina, G. Muckle, S. Bruneau, P. Ayotte, and E. Dewailly, “Neonatal vitamin A deficiency and its impact on acute respiratory infections among preschool Inuit children.,” Can. J. Public Health, vol. 99, no. 2, pp. 102–6, 2008.

[53] J. Jee, A. E. Hoet, M. P. Azevedo, A. N. Vlasova, S. C. Loerch, C. L. Pickworth, J. Hanson, and L. J. Saif, “Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine,” Am. J. Vet. Res., vol. 74, no. 10, pp. 1353–1362, Oct. 2013.

[54] C. E. West, S. R. Sijtsma, B. Kouwenhoven, J. H. Rombout, and A. J. van der Zijpp, “Epithelia-damaging virus infections affect vitamin A status in chickens.,” J. Nutr., vol. 122, no. 2, pp. 333–9, Feb. 1992.

[55] Z. Huang, Y. Liu, G. Qi, D. Brand, and S. G. Zheng, “Clinical Medicine Role of Vitamin A in the Immune System,” J. Clin. Med., vol. 7, no. 9, pp. 1–16, 2018.

[56] A. C. Ross, “Vitamin A status: relationship to immunity and the antibody response.,” Proc. Soc. Exp. Biol. Med., vol. 200, no. 3, pp. 303–20, Jul. 1992.

[57] J. M. Strum, P. S. Latham, M. L. Schmidt, and E. M. McDowell, “Vitamin A deprivation in hamsters. Correlations between tracheal epithelial morphology and serum/tissue levels of vitamin A.,” Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol., vol. 50, no. 1, pp. 43–57, 1985.

[58] D. Sklan, D. Melamed, and A. Friedman, “The effect of varying dietary concentrations of vitamin A on immune response in the turkey,” Br. Poult. Sci., vol. 36, no. 3, pp. 385–392, Jul. 1995.

[59] N. Darwiche, G. Celli, L. Sly, F. Lancillotti, and L. M. De Luca, “Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium.,” Cancer Res., vol. 53, no. 10 Suppl, pp. 2287–99, May 1993.

[60] A. Friedman, A. Meidovsky, G. Leitner, and D. Sklan, “Decreased resistance and immune response to Escherichia coli infection in chicks with low or high intakes of vitamin A.,” J. Nutr., vol. 121, no. 3, pp. 395–400, Mar. 1991.

[61] C. J. Field, I. R. Johnson, and P. D. Schley, “Nutrients and their role in host resistance to infection.,” J. Leukoc. Biol., vol. 71, no. 1, pp. 16–32, Jan. 2002.

[62] M. T. Cantorna, F. E. Nashold, and C. E. Hayes, “Vitamin A deficiency results in a priming environment conducive for Th1 cell development,” Eur. J. Immunol., vol. 25, no. 6, pp. 1673–1679, Jun. 1995.

[63] T. Nikawa, K. Odahara, H. Koizumi, Y. Kido, S. Teshima, K. Rokutan, and K. Kishi, “Vitamin A prevents the decline in immunoglobulin A and Th2 cytokine levels in small intestinal mucosa of protein-malnourished mice.,” J. Nutr., vol. 129, no. 5, pp. 934–41, May 1999.

[64] S. S. Twining, D. P. Schulte, P. M. Wilson, B. L. Fish, and J. E. Moulder, “Vitamin A deficiency alters rat neutrophil function.,” J. Nutr., vol. 127, no. 4, pp. 558–65, Apr. 1997.

[65] B. Qian, S. Shen, J. Zhang, and P. Jing, “Effects of Vitamin B6 Deficiency on the Composition and Functional Potential of T Cell Populations,” vol. 2017, p. 2197975, 2017.

[66] S. D. Keil, R. Bowen, and S. Marschner, “Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment,” Transfusion, vol. 56, no. 12, pp. 2948–2952, Dec. 2016.

[67] H. D. Jones, J. Yoo, T. R. Crother, P. Kyme, A. Ben-Shlomo, R. Khalafi, C. W. Tseng, W. C. Parks, M. Arditi, G. Y. Liu, and K. Shimada, “Nicotinamide exacerbates hypoxemia in ventilator-induced lung injury independent of neutrophil infiltration,” PLoS One, vol. 10, no. 4, p. e0123460, Apr. 2015.

[68] W. He, S. Hu, X. Du, Q. Wen, X. P. Zhong, X. Zhou, C. Zhou, W. Xiong, Y. Gao, S. Zhang, R. Wang, J. Yang, and L. Ma, “Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis,” Front. Immunol., vol. 9, p. 365, Feb. 2018.

[69] L. C. Rail and S. N. Meydani, “Vitamin B6 and Immune Competence,” Nutr. Rev., vol. 51, no. 8, pp. 217–225, Apr. 2009.

[70] A. M. Gori, F. Sofi, A. M. Corsi, A. Gazzini, I. Sestini, F. Lauretani, S. Bandinelli, G. F. Gensini, L. Ferrucci, and R. Abbate, “Predictors of vitamin B6 and folate concentrations in older persons: The InCHIANTI study,” Clin. Chem., vol. 52, no. 7, pp. 1318–1324, Jul. 2006.

[71] R. Gay and S. N. Meydani, “The Effects of Vitamin E, Vitamin B6, and Vitamin B12 on Immune Function,” Nutr. Clin. Care, vol. 4, no. 4, pp. 188–198, Jul. 2001.

[72] S. Maggini, E. S. Wintergerst, S. Beveridge, and D. H. Hornig, “Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses,” in British Journal of Nutrition, 2007, vol. 98, no. SUPPL. 1, pp. S29-35.

[73] L. C. Rail and S. N. Meydani, “Vitamin B6 and Immune Competence,” Nutr. Rev., vol. 51, no. 8, pp. 217–225, Aug. 1993.

[74] G. Liu, C. Sun, H. Liu, F. Li, Y. Zhu, and F. Li, “Effects of dietary supplement of vitamin B6 on growth performance and non-specific immune response of weaned rex rabbits,” J. Appl. Anim. Res., vol. 46, no. 1, pp. 1370–1376, Jan. 2018.

[75] A. Rocco, D. Compare, P. Coccoli, C. Esposito, A. Di Spirito, A. Barbato, P. Strazzullo, and G. Nardone, “Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus,” Gut, vol. 62, no. 5, pp. 766–773, May 2013.

[76] S. Lewicki, A. Lewicka, B. Kalicki, A. Kłos, J. Bertrandt, and R. Zdanowdki, “The influence of vitamin B12 supplementation on the level of white blood cells and lymphocytes phenotype in rats fed a low-protein diet,” Cent. Eur. J. Immunol., vol. 39, no. 4, pp. 419–425, 2014.

[77] A. M. Tang, N. M. Graham, R. K. Chandra, and A. J. Saah, “Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression.,” J. Nutr., vol. 127, no. 2, pp. 345–51, Feb. 1997.

[78] C. C. Lin, W. H. Liu, Z. H. Wang, and M. C. Yin, “Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection,” Eur. J. Nutr., vol. 50, no. 7, pp. 499–506, Oct. 2011.

[79] B. H. Tina Suksmasari, “Multivitamin Supplementation Supports Immune Function and Ameliorates Conditions Triggered By Reduced Air Quality,” Vitam. Miner., vol. 04, no. 02, pp. 1–15, May 2015.

[80] C. Courtemanche, I. Elson-Schwab, S. T. Mashiyama, N. Kerry, and B. N. Ames, “ Folate Deficiency Inhibits the Proliferation of Primary Human CD8 + T Lymphocytes In Vitro ,” J. Immunol., vol. 173, no. 5, pp. 3186–3192, Sep. 2004.

[81] H. Hemilä, “Vitamin C and SARS coronavirus,” J. Antimicrob. Chemother., vol. 52, no. 6, pp. 1049–1050, 2003.

[82] A. W. Ashor, J. Lara, J. C. Mathers, and M. Siervo, “Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials,” Atherosclerosis, vol. 235, no. 1. Elsevier Ireland Ltd, pp. 9–20, Jul-2014.

[83] A. W. Ashor, M. Siervo, J. Lara, C. Oggioni, S. Afshar, and J. C. Mathers, “Effect of vitamin C and vitamin e supplementation on endothelial function: A systematic review and meta-analysis of randomised controlled trials,” Br. J. Nutr., vol. 113, no. 8, pp. 1182–1194, 2015.

[84] H. Hemilä and T. Suonsyrjä, “Vitamin C for preventing atrial fibrillation in high risk patients: A systematic review and meta-analysis,” BMC Cardiovasc. Disord., vol. 17, no. 1, p. 49, Feb. 2017.

[85] R. Shi, Z. H. Li, D. Chen, Q. C. Wu, X. L. Zhou, and H. T. Tie, “Sole and combined vitamin C supplementation can prevent postoperative atrial fibrillation after cardiac surgery: A systematic review and meta-analysis of randomized controlled trials,” Clin. Cardiol., vol. 41, no. 6, pp. 871–878, Jun. 2018.

[86] S. P. Juraschek, E. Guallar, L. J. Appel, and E. R. Miller, “Effects of vitamin c supplementation on blood pressure: A meta-analysis of randomized controlled trials,” Am. J. Clin. Nutr., vol. 95, no. 5, pp. 1079–1088, May 2012.

[87] C. Ramos, R. Brito, J. González-Montero, N. Valls, J. G. Gormaz, J. C. Prieto, R. Aguayo, Á. Puentes, V. Noriega, G. Pereira, T. Palavecino, and R. Rodrigo, “Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty,” Arch. Med. Sci., vol. 13, no. 3, pp. 558–567, 2017.

[88] N. Valls, J. G. Gormaz, R. Aguayo, J. González, R. Brito, D. Hasson, M. Libuy, C. Ramos, R. Carrasco, J. C. Prieto, G. Dussaillant, Á. Puentes, V. Noriega, and R. Rodrigo, “Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction,” Redox Rep., vol. 21, no. 2, pp. 75–83, Mar. 2016.

[89] H. Hemilä, “Vitamin C and infections,” Nutrients, vol. 9, no. 4, p. 339, Apr. 2017.

[90] H. Hemilä and E. Chalker, “Vitamin C for preventing and treating the common cold,” Cochrane Database Syst. Rev., vol. 2013, no. 5, pp. 1–2, 2013.

[91] H. Hemilä, “The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: A review and statistical analysis,” Allergy, Asthma and Clinical Immunology, vol. 10, no. 1. BioMed Central Ltd., p. 58, Nov-2014.

[92] H. Hemilä and E. Chalker, “Vitamin C can shorten the length of stay in the ICU: A meta-analysis,” Nutrients, vol. 11, no. 4, Apr. 2019.

[93] B. J. Fisher, D. Kraskauskas, E. J. Martin, D. Farkas, J. A. Wegelin, D. Brophy, K. R. Ward, N. F. Voelkel, A. A. Fowler, and R. Natarajan, “Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid,” Am. J. Physiol. - Lung Cell. Mol. Physiol., vol. 303, no. 1, pp. L20-32, Jul. 2012.

[94] B. J. Fisher, I. M. Seropian, D. Kraskauskas, J. N. Thakkar, N. F. Voelkel, A. A. Fowler, and R. Natarajan, “Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury,” Crit. Care Med., vol. 39, no. 6, pp. 1454–1460, Jun. 2011.

[95] J. G. Atherton, C. C. Kratzing, and A. Fisher, “The effect of ascorbic acid on infection chick-embryo ciliated tracheal organ cultures by coronavirus.,” Arch. Virol., vol. 56, no. 3, pp. 195–9, 1978.

[96] T. Cui, Y. Lai, J. S. Janicki, and X. Wang, “Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytes,” Front. Biosci. (Landmark Ed., vol. 21, pp. 192–202, 2016.

[97] Q. Liu, Y. Gao, and X. Ci, “Role of Nrf2 and Its Activators in Respiratory Diseases,” Oxid. Med. Cell. Longev., vol. 2019, pp. 1–17, 2019.

[98] B. Sobha Kumari and R. K. Chandra, “Overnutrition and immune responses,” Nutr. Res., vol. 13, no. SUPPL. 1, pp. S3–S18, Jan. 1993.

[99] M. Maares and H. Haase, “Zinc and immunity: An essential interrelation,” Arch. Biochem. Biophys., vol. 611, pp. 58–65, Dec. 2016.

[100] R. L. Atmar, P. A. Piedra, S. M. Patel, S. B. Greenberg, R. B. Couch, and W. P. Glezen, “Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness,” J. Clin. Microbiol., vol. 50, no. 2, pp. 506–508, Feb. 2012.

[101] B. D. Korant, J. C. Kauer, and B. E. Butterworth, “Zinc ions inhibit replication of rhinoviruses,” Nature, vol. 248, no. 5449, pp. 588–590, 1974.

[102] S. B. Mossad, M. L. Macknin, S. V. Medendorp, and P. Mason, “Zinc Gluconate Lozenges for Treating the Common Cold: A Randomized, Double-Blind, Placebo-Controlled Study,” Ann. Intern. Med., vol. 125, no. 2, pp. 81–88, Jul. 1996.

[103] W. Chai, S. S. Zakrzewski, D. Günzel, R. Pieper, Z. Wang, S. Twardziok, P. Janczyk, N. Osterrieder, and M. Burwinkel, “High-dose dietary zinc oxide mitigates infection with transmissible gastroenteritis virus in piglets,” BMC Vet. Res., vol. 10, no. 1, p. 75, Mar. 2014.

[104] N. Samad, T. E. Sodunke, A. R. Abubakar, I. Jahan, P. Sharma, S. Islam, S. Dutta, and M. Haque, “The implications of zinc therapy in combating the covid-19 global pandemic,” J. Inflamm. Res., vol. 14, pp. 527–550, 2021.

[105] S. Overbeck, L. Rink, and H. Haase, “Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases,” Arch. Immunol. Ther. Exp. (Warsz)., vol. 56, no. 1, pp. 15–30, 2008.

[106] M. Singh and R. R. Das, “Zinc for the common cold,” Cochrane Database Syst. Rev., no. 6, 2013.

[107] S.-C. Chen, K.-S. Jeng, and M. M. C. Lai, “Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.,” J. Virol., vol. 91, no. 20, pp. e00842-17, 2017.

[108] S. A. Read, G. Parnell, D. Booth, M. W. Douglas, J. George, and G. Ahlenstiel, “The antiviral role of zinc and metallothioneins in hepatitis C infection,” J. Viral Hepat., vol. 25, no. 5, pp. 491–501, May 2018.

[109] M. Kar, N. A. Khan, A. Panwar, S. S. Bais, S. Basak, R. Goel, S. Sopory, and G. R. Medigeshi, “Zinc Chelation Specifically Inhibits Early Stages of Dengue Virus Replication by Activation of NF-κB and Induction of Antiviral Response in Epithelial Cells,” Front. Immunol., vol. 10, p. 2347, Oct. 2019.

[110] W. Sommergruber, G. Casari, F. Fessl, J. Seipelt, and T. Skern, “The 2A proteinase of human rhinovirus is a zinc containing enzyme,” Virology, vol. 204, no. 2, pp. 815–818, Nov. 1994.

[111] M. J. H. Nicklin, H. Toyoda, M. G. Murray, and E. Wimmer, “Proteolytic processing in the replication of polio and related viruses,” Bio/Technology, vol. 4, no. 1, pp. 33–42, 1986.

[112] D. L. Hatfield, P. A. Tsuji, B. A. Carlson, and V. N. Gladyshev, “Selenium and selenocysteine: Roles in cancer, health, and development,” Trends in Biochemical Sciences, vol. 39, no. 3. pp. 112–120, 2014.

[113] L. V. Papp, A. Holmgren, and K. K. Khanna, “Selenium and selenoproteins in health and disease,” Antioxidants Redox Signal., vol. 12, no. 7, pp. 793–795, Apr. 2010.

[114] L. A. Seale, A. N. Ogawa-Wong, and M. J. Berry, “Sexual Dimorphism in Selenium metabolism and seleneoproteins,” Free Radic. Biol. Med., vol. 127, pp. 198–205, Nov. 2018.

[115] X. Ma, S. Bi, Y. Wang, X. Chi, and S. Hu, “Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens.,” Poult. Sci., vol. 98, no. 9, pp. 3548–3556, Sep. 2019.

[116] M. A. Beck, Q. Shi, V. C. Morris, and O. A. Levander, “Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates,” Nat. Med., vol. 1, no. 5, pp. 433–436, May 1995.

[117] H. K. Nelson, Q. Shi, P. Van Dael, E. J. Schiffrin, S. Blum, D. Barclay, O. A. Levander, and M. A. Beck, “Host nutritional selenium status as a driving force for influenza virus mutations,” FASEB J., vol. 15, no. 10, pp. 1846–1848, 2001.

[118] J. Zhang, E. W. Taylor, K. Bennett, R. Saad, and M. P. Rayman, “Association between regional selenium status and reported outcome of COVID-19 cases in China,” American Journal of Clinical Nutrition, vol. 111, no. 6. Oxford University Press, pp. 1297–1299, Jun-2020.

[119] O. M. Guillin, C. Vindry, T. Ohlmann, and L. Chavatte, “Selenium, selenoproteins and viral infection,” Nutrients, vol. 11, no. 9, p. 2101, 2019.

[120] M. Harthill, “Review: Micronutrient selenium deficiency influences evolution of some viral infectious diseases,” Biol. Trace Elem. Res., vol. 143, no. 3, pp. 1325–1336, 2011.

[121] L. Kiremidjian-Schumacher, M. Roy, H. I. Wishe, M. W. Cohen, and G. Stotzky, “Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells,” Biol. Trace Elem. Res., vol. 52, no. 3, pp. 227–239, Jun. 1996.

[122] F. W. Beck, A. S. Prasad, J. Kaplan, J. T. Fitzgerald, and G. J. Brewer, “Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans.,” Am. J. Physiol., vol. 272, no. 6 Pt 1, pp. E1002-7, Jun. 1997.

[123] J. E. Cassat and E. P. Skaar, “Iron in infection and immunity,” Cell Host Microbe, vol. 13, no. 5, pp. 509–519, May 2013.

[124] H. Drakesmith and A. Prentice, “Viral infection and iron metabolism,” Nat. Rev. Microbiol., vol. 6, no. 7, pp. 541–552, 2008.

[125] P. Piccinelli and T. Samuelsson, “Evolution of the iron-responsive element,” RNA, vol. 13, no. 7, pp. 952–966, Jul. 2007.

[126] R. K. Chandyo, S. Henjum, M. Ulak, A. L. Thorne-Lyman, R. J. Ulvik, P. S. Shrestha, L. Locks, W. Fawzi, and T. A. Strand, “The prevalence of anemia and iron deficiency is more common in breastfed infants than their mothers in Bhaktapur, Nepal,” Eur. J. Clin. Nutr., vol. 70, no. 4, pp. 456–462, Apr. 2016.

[127] R. K. Chandra, “Reduced bactericidal capacity of polymorphs in iron deficiency,” Arch. Dis. Child., vol. 48, no. 11, pp. 864–866, 1973.

[128] S. Mourad, M. Rajab, A. Alameddine, M. Fares, F. Ziade, and B. Merhi, “Hemoglobin level as a risk factor for lower respiratory tract infections in Lebanese children,” N. Am. J. Med. Sci., vol. 2, no. 10, pp. 461–466, Oct. 2010.

[129] A. Soyano and M. Gómez, “Role of iron in immunity and its relation with infections,” Archivos latinoamericanos de nutrición, vol. 49. p. 40S–46S, 1999.

[130] H. M. Abdel-Maksoud, K. A. Hasan, and M. A. Helwa, “Evaluation of iron deficiency anemia as a predisposing factor in the occurrence of pneumonia in children,” Trends Med. Res., vol. 11, no. 2, pp. 69–75, 2016.

[131] A. Kohn, J. Gitelman, and M. Inbar, “Unsaturated free fatty acids inactivate animal enveloped viruses,” Arch. Virol., vol. 66, no. 4, pp. 301–307, Dec. 1980.

[132] G. Z. Leu, T. Y. Lin, and J. T. A. Hsu, “Anti-HCV activities of selective polyunsaturated fatty acids,” Biochem. Biophys. Res. Commun., vol. 318, no. 1, pp. 275–280, May 2004.

[133] A. T. Merchant, G. C. Curhan, E. B. Rimm, W. C. Willett, and W. W. Fawzi, “Intake of n−6 and n−3 fatty acids and fish and risk of community-acquired pneumonia in US men,” Am. J. Clin. Nutr., vol. 82, no. 3, pp. 668–674, Sep. 2005.

[134] M. Morita, K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira, R. Iwamoto, T. Watanebe, S. Sakabe, T. Daidoji, S. Nakamura, A. Kadowaki, T. Ohto, H. Nakanishi, R. Taguchi, T. Nakaya, M. Murakami, Y. Yoneda, H. Arai, Y. Kawaoka, J. M. Penninger, M. Arita, and Y. Imai, “The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza,” Cell, vol. 153, no. 1, pp. 112–125, Mar. 2013.

[135] Y. Bromberg and E. Pick, “Unsaturated fatty acids stimulate NADPH-dependent superoxide production by cell-free system derived from macrophages,” Cell. Immunol., vol. 88, no. 1, pp. 213–221, Oct. 1984.

[136] A. Fernández-Quintela, I. Milton-Laskibar, J. Trepiana, S. Gómez-Zorita, N. Kajarabille, A. Léniz, M. González, and M. P. Portillo, “Key Aspects in Nutritional Management of COVID-19 Patients,” J. Clin. Med., vol. 9, no. 8, p. 2589, Aug. 2020.

[137] M. M. Rogero, M. D. C. Leão, T. M. Santana, and M. V. D. M. B. Pimentel, “Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19,” Free Radic. Biol. Med., no. January, pp. 190–199, 2020.

[138] M. M. Rogero, M. de C. Leão, T. M. Santana, M. V. d. M. B. Pimentel, G. C. G. Carlini, T. F. F. da Silveira, R. C. Gonçalves, and I. A. Castro, “Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19,” Free Radical Biology and Medicine, vol. 156. Elsevier Inc., pp. 190–199, Aug-2020.

[139] B. R. Bistrian, “Parenteral Fish‐Oil Emulsions in Critically Ill COVID‐19 Emulsions,” J. Parenter. Enter. Nutr., vol. 44, no. 7, pp. 1168–1168, Sep. 2020.

[140] P. Rose, M. Whiteman, P. K. Moore, and Z. Z. Yi, “Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: The chemistry of potential therapeutic agents,” Natural Product Reports, vol. 22, no. 3. Nat Prod Rep, pp. 351–368, Jun-2005.

[141] N. Weber, D. Andersen, J. North, B. Murray, L. Lawson, and B. Hughes, “In Vitro Virucidal Effects of Allium sativum (Garlic) Extract and Compounds,” Planta Med., vol. 58, no. 05, pp. 417–423, Oct. 1992.

[142] T. Mohajer Shojai, A. Ghalyanchi Langeroudi, V. Karimi, A. Barin, and N. Sadri, “The effect of Allium sativum (Garlic) extract on infectious bronchitis virus in specific pathogen free embryonic egg.,” Avicenna J. phytomedicine, vol. 6, no. 4, pp. 458–267, 2016.

[143] L. Chen, J. Li, C. Luo, H. Liu, W. Xu, G. Chen, O. W. Liew, W. Zhu, C. M. Puah, X. Shen, and H. Jiang, “Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure-activity relationship studies reveal salient pharmacophore features,” Bioorganic Med. Chem., vol. 14, no. 24, pp. 8295–8306, Dec. 2006.

[144] M. Metin Donma and O. Donma, “The effects of allium sativum on immunity within the scope of COVID-19 infection,” 2020.

[145] W. N. S. Prabodh Satyal , Jonathan D Craft , Noura S Dosoky, “The Chemical Compositions of the Volatile Oils of Garlic (Allium sativum) and Wild Garlic (Allium vineale),” Foods, vol. 6, no. 8, p. 63, Aug. 2017.

[146] B. T. P. Thuy, T. T. A. My, N. T. T. Hai, L. T. Hieu, T. T. Hoa, H. Thi Phuong Loan, N. T. Triet, T. T. Van Anh, P. T. Quy, P. Van Tat, N. Van Hue, D. T. Quang, N. T. Trung, V. T. Tung, L. K. Huynh, and N. T. A. Nhung, “Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil,” ACS Omega, vol. 5, no. 5312–5320, 2020.

[147] F. Forouzanfar, B. S. Fazly Bazzaz, and H. Hosseinzadeh, “Black cumin (Nigella sativa) and its constituent (thymoquinone): A review on antimicrobial effects,” Iran. J. Basic Med. Sci., vol. 17, no. 12, pp. 929–938, 2014.

[148] M. L. Salem and M. S. Hossain, “Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection,” Int. J. Immunopharmacol., vol. 22, no. 9, pp. 729–740, Sep. 2000.

[149] A. A. Onifade, A. P. Jewell, and W. A. Adedeji, “Nigella sativa concoction induced sustained seroreversion in HIV patient.,” Afr. J. Tradit. Complement. Altern. Med., vol. 10, no. 5, pp. 332–335, 2013.

[150] M. Ulasli, S. A. Gurses, R. Bayraktar, O. Yumrutas, S. Oztuzcu, M. Igci, Y. Z. Igci, E. A. Cakmak, and A. Arslan, “The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family,” Mol. Biol. Rep., vol. 41, no. 3, pp. 1703–1711, Mar. 2014.

[151] D. A. E. Koshak and P. E. A. Koshak, “Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies,” Current Therapeutic Research - Clinical and Experimental, vol. 93. Excerpta Medica Inc., p. 100602, Jan-2020.

[152] M. H. Boskabady, N. Mohsenpoor, and L. Takaloo, “Antiasthmatic effect of Nigella sativa in airways of asthmatic patients,” Phytomedicine, vol. 17, no. 10, pp. 707–713, Aug. 2010.

[153] A. M. Salem, A. O. Bamosa, H. O. Qutub, R. K. Gupta, A. Badar, A. Elnour, and M. N. Afzal, “Effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma: A randomized controlled trial,” Ann. Saudi Med., vol. 37, no. 1, pp. 64–71, Jan. 2017.

[154] E. M. F. Barakat, L. M. El Wakeel, and R. S. Hagag, “Effects of Nigella sativa on outcome of hepatitis C in Egypt,” World J. Gastroenterol., vol. 19, no. 16, pp. 2529–2536, Apr. 2013.

[155] C. Feng Yeh, K. Chih Wang, L. Chai Chiang, D. E. Shieh, M. Hong Yen, and J. San Chang, “Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines,” J. Ethnopharmacol., vol. 148, no. 2, pp. 466–473, Jul. 2013.

[156] G. Hoever, L. Baltina, M. Michaelis, R. Kondratenko, L. Baltina, G. A. Tolstikov, H. W. Doerr, and J. Cinatl, “Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus,” J. Med. Chem., vol. 48, no. 4, pp. 1256–1259, Feb. 2005.

[157] J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr, “Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus,” Lancet, vol. 361, no. 9374, pp. 2045–2046, Jun. 2003.

[158] H. Ding, W. Deng, L. Ding, X. Ye, S. Yin, and W. Huang, “Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID‐19 patients,” J. Med. Virol., vol. 92, no. 10, pp. 2200–2204, Oct. 2020.

[159] C. Fiore, M. Eisenhut, R. Krausse, E. Ragazzi, D. Pellati, D. Armanini, and J. Bielenberg, “Antiviral effects ofGlycyrrhiza species,” Phyther. Res., vol. 22, no. 2, pp. 141–148, Feb. 2008.

[160] H. G. Jeong and J. Y. Kim, “Induction of inducible nitric oxide synthase expression by 18β-glycyrrhetinic acid in macrophages,” FEBS Lett., vol. 513, no. 2–3, pp. 208–212, Feb. 2002.

[161] C. Wang, D. Shi, F. Zhang, X. Yu, G. Lin, and Z. Zhou, “Characterization of binding interaction between magnesium isoglycyrrhizinate and human serum albumin,” Spectrochim. Acta - Part A Mol. Biomol. Spectrosc., vol. 234, p. 118245, Jun. 2020.

[162] S. Harada, “The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope,” Biochem. J., vol. 392, no. 1, pp. 191–199, Nov. 2005.

[163] P. Luo, D. Liu, and J. Li, “Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19,” Int. J. Antimicrob. Agents, vol. 55, no. 6, p. 105995, Jun. 2020